US 11633385
Combination compositions for treatment of cancer
granted A61KA61K31/435A61K31/438
Quick answer
US patent 11633385 (Combination compositions for treatment of cancer) held by RedHill Biopharma Ltd. expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/495